RIPK1 and hepatocellular carcinoma: Hepatocyte-specific deletion of endogenous inhibitor of RIPK1 kinase, such as TAK1—which performs inhibitory phosphorylation on RIPK1—leads to spontaneous hepatocyte apoptosis, steatohepatitis, fibrosis and hepatocellular carcinoma (HCC)52,53.